Last edition
News about "nilotinib orally disintegrating tablets"
Cycle Pharma Selects Forma Life Sciences for US Supply of FDA-Approved CAVHANZA
Cycle Pharmaceuticals selects Forma Life Sciences to establish US commercial supply of Food and Drug Administration (FDA)-approved CAVHANZA (nilotinib) for Philadelphia chromosome-positive CML patients.
Nilotinib Orally Disintegrating Tablets | 13/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members